Clinical Trials

ClinicalTrials.gov registrations across deep tech.

Showing 24 of 19,428 clinical trials

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

NCT07563296Started 12 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Irma Fleming

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 1, Multi-center, Single-dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of Golcadomide (BMS-986369) in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

NCT07763418Started 12 days ago

PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Bristol-Myers Squibb

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase I, Multicentre, Single-Dose, Non-Randomised, Open-Label, Parallel-Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD4144

NCT07783308Started 12 days ago

PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: AstraZeneca

Source: ClinicalTrials.gov · Synced 4 days ago

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

NCT07775495Started 15 days ago

NOT_YET_RECRUITINGOBSERVATIONAL

Sponsor: Ecotera Health LLC

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase III Randomized, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 in Participants With Type 2 Diabetes Mellitus and Obesity or Overweight (SELENE 2)

NCT07784270Started 15 days ago

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: AstraZeneca

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase III Randomised, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 as an Adjunct to Incretin-based Therapies in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity With or Without Type 2 Diabetes Mellitus (SELENE 3)

NCT07776509Started 15 days ago

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: AstraZeneca

Source: ClinicalTrials.gov · Synced 4 days ago

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

NCT07705373Started 16 days ago

NARECRUITINGINTERVENTIONAL

Sponsor: Boston University Charles River Campus

Source: ClinicalTrials.gov · Synced 4 days ago

A Randomized, Double-blind, Multi-regional Phase 3 Study of Cadonilimab Combined With Chemotherapy Versus Chemotherapy in Combination With or Without Nivolumab for the First-line Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

NCT07700979Started 16 days ago

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Akeso

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase III Randomised, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity Without Type 2 Diabetes Mellitus (SELENE 1)

NCT07784725Started 17 days ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: AstraZeneca

Source: ClinicalTrials.gov · Synced 4 days ago

Phase 1/2a Open-Label Clinical Trial Evaluating VBC106, an FRα- and MSLN-Directed Bispecific Antibody Drug Conjugate, in Participants With Advanced Malignant Solid Tumors

NCT07686068Started 18 days ago

PHASE1PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: VelaVigo Bio Inc

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 3 Prospective Randomised Clinical Trial of VMX-C001 vs Usual Pharmacological Care in Patients Receiving a FXa Direct Oral Anticoagulant (FXa DOAC) Who Require Urgent Surgery or Other Invasive Procedure That is Associated With a High Risk of Bleeding, With or Without Planned Administration of Heparin (EQUILIBRIX-S)

NCT07288489Started 18 days ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: VarmX B.V.

Source: ClinicalTrials.gov · Synced 4 days ago

Buprenorphine Implementation at Syringe Services Programs To Reduce Overdoses: A Type 1 Hybrid Effectiveness-Implementation Trial

NCT07631598Started 19 days ago

NARECRUITINGINTERVENTIONAL

Sponsor: Montefiore Medical Center

Source: ClinicalTrials.gov · Synced 4 days ago

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652Started 19 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Yale University

Source: ClinicalTrials.gov · Synced 4 days ago

A Prospective, Multicenter, Single-arm Study of Ocrelizumab Administered Subcutaneously in Patients With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

NCT07609719Started 19 days ago

PHASE4NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Genentech, Inc.

Source: ClinicalTrials.gov · Synced about 2 months ago

Randomized Phase II Trial to Evaluate the Efficacy of WSD0922-FU When Combined With Adjuvant Temozolomide in Patients With EGFR Mutant Glioblastoma

NCT07708961Started 20 days ago

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

NCT07746271Started 21 days ago

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: The George Washington University Biostatistics Center

Source: ClinicalTrials.gov · Synced 4 days ago

A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult and Adolescent Participants With Autoimmune Encephalitis

NCT07583641Started 21 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: argenx

Source: ClinicalTrials.gov · Synced 4 days ago

RELIEVE (RandomizEd triaL of Intravesical xEomin for Incontinence Via the VibE System) - a Randomized, Prospective, Multicenter, Double Blind, Placebo and Sham Controlled Study to Assess the Safety and Efficacy of NT 201 Intravesical Administration Using Vibe System in the Treatment of Female Participants Suffering From Idiopathic Overactive Bladder

NCT07553065Started 22 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Vensica Therapeutics Ltd.

Source: ClinicalTrials.gov · Synced 4 days ago

Feasibility and Preliminary Efficacy of Functional MRI-Guided Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder: A Pilot Study

NCT07463703Started 22 days ago

NARECRUITINGINTERVENTIONAL

Sponsor: Cognitive FX

Source: ClinicalTrials.gov · Synced 4 days ago

BOdygUardian MOnitoriNg for ReCurrencE of AF (BOUNCE-AF)

NCT07671677Started 23 days ago

RECRUITINGOBSERVATIONAL

Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Source: ClinicalTrials.gov · Synced 4 days ago

Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough

NCT06960759Started 23 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: University of Montana

Source: ClinicalTrials.gov · Synced 4 days ago

Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Chronic Low Back Pain

NCT07641504Started 24 days ago

PHASE2RECRUITINGINTERVENTIONAL

Sponsor: ELI LILLY AND COMPANY

Source: ClinicalTrials.gov · Synced 4 days ago

Efficacy and Safety of Once Daily Oral Semaglutide in Adults With Overweight or Obesity

NCT07770841Started 24 days ago

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Novo Nordisk A/S

Source: ClinicalTrials.gov · Synced 4 days ago

INSIGHT-IBD Pragmatic Study: Investigation of Mirikizumab in Real World Settings for Mirikizumab

NCT07686757Started 24 days ago

PHASE4ENROLLING_BY_INVITATIONINTERVENTIONAL

Sponsor: Specialty Networks Research.

Source: ClinicalTrials.gov · Synced 4 days ago

Load more (24)

Trial data sourced from ClinicalTrials.gov, a service of the U.S. National Library of Medicine.